CHRNA7 and Alzheimer disease: We have shown that the isomerization of Asp7 enhances the inhibitory effect of Aβ on the functional activity of the α7nAChR, which may be the reason for the increased neurotoxicity of the peptide and an important factor in the pathogenesis of AD.